位置:首页 > 蛋白库 > APOE_PTEAL
APOE_PTEAL
ID   APOE_PTEAL              Reviewed;         308 AA.
AC   L5KM50;
DT   07-APR-2021, integrated into UniProtKB/Swiss-Prot.
DT   07-APR-2021, sequence version 2.
DT   03-AUG-2022, entry version 33.
DE   RecName: Full=Apolipoprotein E;
DE            Short=Apo-E;
DE   Flags: Precursor;
GN   Name=APOE;
OS   Pteropus alecto (Black flying fox).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Chiroptera; Megachiroptera; Pteropodidae;
OC   Pteropodinae; Pteropus.
OX   NCBI_TaxID=9402;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=23258410; DOI=10.1126/science.1230835;
RA   Zhang G., Cowled C., Shi Z., Huang Z., Bishop-Lilly K.A., Fang X.,
RA   Wynne J.W., Xiong Z., Baker M.L., Zhao W., Tachedjian M., Zhu Y., Zhou P.,
RA   Jiang X., Ng J., Yang L., Wu L., Xiao J., Feng Y., Chen Y., Sun X.,
RA   Zhang Y., Marsh G.A., Crameri G., Broder C.C., Frey K.G., Wang L.F.,
RA   Wang J.;
RT   "Comparative analysis of bat genomes provides insight into the evolution of
RT   flight and immunity.";
RL   Science 339:456-460(2013).
CC   -!- FUNCTION: APOE is an apolipoprotein, a protein associating with lipid
CC       particles, that mainly functions in lipoprotein-mediated lipid
CC       transport between organs via the plasma and interstitial fluids. APOE
CC       is a core component of plasma lipoproteins and is involved in their
CC       production, conversion and clearance. Apoliproteins are amphipathic
CC       molecules that interact both with lipids of the lipoprotein particle
CC       core and the aqueous environment of the plasma. As such, APOE
CC       associates with chylomicrons, chylomicron remnants, very low density
CC       lipoproteins (VLDL) and intermediate density lipoproteins (IDL) but
CC       shows a preferential binding to high-density lipoproteins (HDL). It
CC       also binds a wide range of cellular receptors including the LDL
CC       receptor/LDLR and the very low-density lipoprotein receptor/VLDLR that
CC       mediate the cellular uptake of the APOE-containing lipoprotein
CC       particles. Finally, APOE has also a heparin-binding activity and binds
CC       heparan-sulfate proteoglycans on the surface of cells, a property that
CC       supports the capture and the receptor-mediated uptake of APOE-
CC       containing lipoproteins by cells. {ECO:0000250|UniProtKB:P02649}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P02649}.
CC       Secreted, extracellular space {ECO:0000250|UniProtKB:P02649}. Secreted,
CC       extracellular space, extracellular matrix
CC       {ECO:0000250|UniProtKB:P02649}. Note=In the plasma, APOE is associated
CC       with chylomicrons, chylomicrons remnants, VLDL, LDL and HDL
CC       lipoproteins. Lipid poor oligomeric APOE is associated with the
CC       extracellular matrix in a calcium- and heparan-sulfate proteoglycans-
CC       dependent manner. Lipidation induces the release from the extracellular
CC       matrix. {ECO:0000250|UniProtKB:P02649}.
CC   -!- PTM: APOE exists as multiple glycosylated and sialylated glycoforms
CC       within cells and in plasma. The extent of glycosylation and sialylation
CC       are tissue and context specific. {ECO:0000250|UniProtKB:P02649}.
CC   -!- PTM: Glycated in plasma VLDL. {ECO:0000250|UniProtKB:P02649}.
CC   -!- PTM: Phosphorylated by FAM20C in the extracellular medium.
CC       {ECO:0000250|UniProtKB:P02649}.
CC   -!- SIMILARITY: Belongs to the apolipoprotein A1/A4/E family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KB030659; ELK12734.1; -; Genomic_DNA.
DR   RefSeq; XP_006911850.1; XM_006911788.2.
DR   RefSeq; XP_015444823.1; XM_015589337.1.
DR   AlphaFoldDB; L5KM50; -.
DR   SMR; L5KM50; -.
DR   STRING; 9402.XP_006911850.1; -.
DR   GeneID; 102889566; -.
DR   KEGG; pale:102889566; -.
DR   CTD; 348; -.
DR   eggNOG; ENOG502QVD6; Eukaryota.
DR   InParanoid; L5KM50; -.
DR   Proteomes; UP000010552; Unassembled WGS sequence.
DR   GO; GO:0042627; C:chylomicron; IEA:UniProtKB-KW.
DR   GO; GO:0034364; C:high-density lipoprotein particle; IEA:UniProtKB-KW.
DR   GO; GO:0034361; C:very-low-density lipoprotein particle; IEA:UniProtKB-KW.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0006869; P:lipid transport; IEA:UniProtKB-KW.
DR   GO; GO:0042157; P:lipoprotein metabolic process; IEA:InterPro.
DR   InterPro; IPR000074; ApoA_E.
DR   Pfam; PF01442; Apolipoprotein; 1.
PE   3: Inferred from homology;
KW   Chylomicron; Extracellular matrix; Glycoprotein; HDL; Heparin-binding;
KW   Lipid transport; Lipid-binding; Oxidation; Phosphoprotein;
KW   Reference proteome; Repeat; Secreted; Signal; Transport; VLDL.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..308
FT                   /note="Apolipoprotein E"
FT                   /id="PRO_5003969348"
FT   REPEAT          75..96
FT                   /note="1"
FT   REPEAT          97..118
FT                   /note="2"
FT   REPEAT          119..140
FT                   /note="3"
FT   REPEAT          141..162
FT                   /note="4"
FT   REPEAT          163..184
FT                   /note="5"
FT   REPEAT          185..206
FT                   /note="6"
FT   REPEAT          207..224
FT                   /note="7"
FT   REPEAT          225..246
FT                   /note="8"
FT   REGION          75..246
FT                   /note="8 X 22 AA approximate tandem repeats"
FT   REGION          153..163
FT                   /note="LDL and other lipoprotein receptors binding"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
FT   REGION          205..281
FT                   /note="Lipid-binding and lipoprotein association"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
FT   REGION          257..308
FT                   /note="Homooligomerization"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
FT   REGION          269..281
FT                   /note="Specificity for association with VLDL"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
FT   BINDING         157..160
FT                   /ligand="heparin"
FT                   /ligand_id="ChEBI:CHEBI:28304"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
FT   BINDING         220..227
FT                   /ligand="heparin"
FT                   /ligand_id="ChEBI:CHEBI:28304"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
SQ   SEQUENCE   308 AA;  35335 MW;  A97BB5A760CB5725 CRC64;
     MKFLWAALVV TLLAGCQADV EEEVKLGQEP DRWQAKQPWE QALGRFWEYL RWVQTLSNKV
     KEELLNSQVT EELKLLIEET MKEVKAYKEE LEKQVGPIAQ ETQARLSKEL QAAQARLESD
     MEDVRTRLAQ YRSEAQAALG QNTDDLQGRL ASHLRKLRKR LLRDAEDLQK RLAVYQAGTH
     EAAERGVSAI HERLGPLMME GPLQAIPPSQ QLRERAEAWG QKVRGRLESV GSQARDRLDD
     VRDQMEELKA KVEEQASQVR LQAEAFQTRL KSWFEPLVQD MQRQWASLVE KVQSSLGISP
     STKPSKTK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024